PEX6 (Peroxisome Biogenesis Factor 6) is a key AAA ATPase protein essential for peroxisome biogenesis and function. It partners with PEX1 in the peroxisomal targeting receptor recycling pathway and plays critical roles in maintaining cellular homeostasis, particularly in neurons where peroxisomes are essential for lipid metabolism and reactive oxygen species (ROS) detoxification[1].
| Property | Value |
|---|---|
| Protein Name | Pex6p (Peroxin-6) |
| Gene | PEX6 |
| UniProt ID | Q9Y5X3 |
| Molecular Weight | ~104 kDa |
| Subcellular Localization | Peroxisomal membrane and cytosol |
| AAA ATPase Family | Type I peroxin |
| Chromosomal Location | 6p21.1 |
PEX6 is a member of the AAA (ATPases Associated with diverse cellular Activities) family:
The protein forms a hexameric complex with PEX1, using ATP hydrolysis to generate mechanical force for extracting PEX5 from the peroxisomal membrane[2]. Structurally, PEX6 shares homology with other AAA ATPases including CDC48/p97 and NSF, which perform similar protein extraction functions in other cellular compartments.
The primary function of PEX6 (with PEX1) is recycling the peroxisomal targeting receptor PEX5:
PEX6 is essential for peroxisome biogenesis:
Peroxisomes are essential for:
PEX6 mutations cause autosomal recessive peroxisome biogenesis disorders within the Zellweger spectrum[4]:
| Disorder | Phenotype Severity | Key Features |
|---|---|---|
| Zellweger Syndrome | Severe | Craniofacial dysmorphism, severe neurological impairment, liver dysfunction, early death |
| Neonatal Adrenoleukodystrophy (NALD) | Intermediate | Progressive neurodegeneration, adrenal insufficiency |
| Infantile Refsum Disease | Milder | Sensorineural hearing loss, retinal degeneration, developmental delay |
Recessive PEX6 mutations cause RCDP4, characterized by:
A milder peroxisome biogenesis disorder caused by PEX6 mutations:
While not directly causative, peroxisomal dysfunction contributes to:
Alzheimer's Disease:
Parkinson's Disease:
Amyotrophic Lateral Sclerosis (ALS):
PEX6 is ubiquitously expressed with highest levels in:
In the brain, PEX6 is expressed in:
The Allen Brain Atlas shows widespread expression across brain regions with particularly high expression in metabolically active neuronal populations.
Over 40 pathogenic PEX6 mutations have been identified:
| Mutation Type | Examples | Effect |
|---|---|---|
| Missense | p.Y428C, p.L664P | Reduced ATPase activity |
| Nonsense | p.R398X, p.Q857X | Truncated protein |
| Frameshift | c.1654delC | Loss of function |
| Splice site | c.2128-1G>A | Aberrant splicing |
Gene Therapy:
Pharmacological:
Supportive:
The study of peroxisome biogenesis factors has revealed critical insights into cellular metabolism and neurodegenerative disease mechanisms. PEX6, as a key component of the peroxisomal protein import machinery, is essential for maintaining peroxisome function across all tissues, with particular importance in neurons that rely on peroxisomal lipid metabolism and antioxidant defense[6].
Historical milestones in peroxisome research include Christian de Duve's discovery of peroxisomes (Nobel Prize, 1974), identification of the peroxisome biogenesis pathway, and more recent advances in understanding the structure and function of the PEX1-PEX6 AAA ATPase complex. These discoveries have direct implications for understanding and treating peroxisome biogenesis disorders and related neurodegenerative conditions.
Steinberg D, et al. (2004). PEX6 in peroxisome biogenesis. Human Molecular Genetics. 13(18):2051-2057. DOI ↩︎
Gardner BM, et al. (2015). The peroxisomal AAA ATPase complex prevents the accumulation of aggregation-prone proteins. Nature Cell Biology. 17(10):1278-1289. DOI ↩︎
Francisco T, et al. (2017). Peroxisome biogenesis: The peroxisomal importomer. Cellular and Molecular Life Sciences. 74(9):1567-1582. DOI ↩︎
Steinberg S, et al. (2015). Peroxisome biogenesis disorders: phenotypic spectrum, pathophysiology and therapeutic approaches. Orphanet Journal of Rare Diseases. 10:7. DOI ↩︎
Van Vliet T, et al. (2020). Peroxisomes in Alzheimer's disease: Inflammasome activation and oxidative stress. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(10):165936. DOI ↩︎
Waterham HR, et al. (2014). Peroxisome biogenesis disorders. Annual Review of Biochemistry. 83:523-553. DOI ↩︎